AIAlexandria N. Iannucci

Alexandria N. Iannucci

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexandria N. Iannucci has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    17β-estradiol status alters NMDAR function and antipsychotic-like activity in female rats

    by Kimberly M. Holter, McKenna G. Klausner, Mary Hunter Hite, Carson T. Moriarty, Samuel H. Barth, Bethany E. Pierce, Alexandria N. Iannucci, Douglas J. Sheffler, Nicholas D. P. Cosford, Heather A. Bimonte-Nelson, et al.

    Low 17β-estradiol (E2) in females of reproductive age, and marked E2 decline with menopause, contributes to heightened symptom severity in schizophrenia (i.e. cognitive dysfunction) and diminished response to antipsychotic medications. However, the underlying mechanisms are unknown. N-methyl-D-aspartate receptor (NMDAR) hypofunction contributes to the pathophysiology of schizophrenia, yet impact of E2 depletion on NMDAR function is not well characterized. Quantitative electroencephalography (qEEG), specifically gamma power, is a well-established functional readout of cortical activity that is elevated in patients with schizophrenia and is sensitive to alterations in NMDAR function. Using qEEG and touchscreen cognitive assessments, present studies investigated the effects of E2 on NMDAR function by administering MK-801 (NMDAR antagonist) to ovariectomized rats with or without E2 implants (Ovx+E and Ovx, respectively). Ovx rats were more sensitive to MK-801-induced elevations in gamma power and attentional impairments compared to Ovx+E rats. Further investigation revealed these effects were mediated by reduced synaptic GluN2A expression. Consistent with clinical reports, olanzapine (second-generation antipsychotic) was less effective in mitigating MK-801-induced elevations in gamma power in Ovx rats. Lastly, we examined antipsychotic-like activity of a Group II metabotropic glutamate receptor (mGlu2/3) positive allosteric modulator (PAM), SBI-0646535, as a novel therapeutic in E2-deprived conditions. SBI-0646535 reversed MK-801-induced elevations in gamma power regardless of E2 status. Collectively, these studies established a relationship between E2 deprivation and NMDAR function that is in part GluN2A-dependent, supporting the notion that E2 deprivation increases susceptibility to NMDAR hypofunction. This highlights the need to examine age/hormone-specific factors when considering antipsychotic response and designing novel pharmacotherapies.


  • Discriminative stimulus properties of two training doses of gabapentin in rats: Substitution by pregabalin, diazepam, and pentobarbital.

    by Adam J. Prus, Madeline T. Van Fossen, Alexandria N. Iannucci, Alexia G. Dalton, Joshua N. Prete

    Gabapentin is used for the treatment of many conditions, including seizures, pain, and anxiety. Increasing reports of nonprescribed use suggest that gabapentin may elicit positive subjective effects. The present study was conducted to examine the subjective effects of gabapentin using rats trained to discriminate either a 30.0 mg/kg or 300.0 mg/kg dose of gabapentin versus vehicle on a two-choice drug discrimination task. Both doses of gabapentin were established as discriminative stimuli, and the 300.0 mg/kg dose was more readily established compared to the 30.0 mg/kg dose. Full substitution (> 80% gabapentin-lever responding) occurred by the training drug and by the gabapentinoid compound pregabalin. Partial substitution (> 20% gabapentin-lever responding) was shown by the opioid compounds morphine and fentanyl, and dose combinations of the opioid receptor antagonist naltrexone with the gabapentin training doses reduced the percentage of gabapentin-lever responding to below 80%. Partial substitution for both training doses of gabapentin occurred with the cannabinoid Δ⁹-tetrahydrocannabinol. The barbiturate compound pentobarbital and the benzodiazepine compound diazepam were only tested for substitution for the 300.0 mg/kg dose of gabapentin and these compounds produced full substitution. These findings demonstrate that gabapentin establishes a robust discriminative cue and exhibits stimulus effects closely similar to pregabalin, pentobarbital, and diazepam. Since pregabalin, pentobarbital, and diazepam carry a risk of problematic use and are classified as controlled substances, further evaluations of gabapentin's risks in this regard are warranted. (PsycInfo Database Record (c) 2024 APA, all rights reserved).


  • Open Access

    G-Quadruplex Structure in the ATP-Binding DNA Aptamer Strongly Modulates Ligand Binding Activity

    by Aleah N. Edwards, Alexandria N. Iannucci, Jacob VanDenBerg, Annastiina Kesti, Tommie Rice, Srishty Sethi, Soma Dhakal, Philip M. Yangyuoru

    Secondary structures formed by single-stranded DNA aptamers can allow for the binding of small-molecule ligands. Some of these secondary structures are highly stable in solution and are great candidates for use in the development of molecular tools for biomarker detection, environmental monitoring, and others. In this paper, we explored adenosine triphosphate (ATP)-binding aptamers for the simultaneous detection of two small-molecule ligands: adenosine triphosphate (ATP) and thioflavin T (ThT). The aptamer can form a G-quadruplex (G4) structure with two G-quartets, and our results show that each of these quartets is equally involved in binding. Using fluorescently labeled and label-free methods, we further explored the role of the G4 motif in modulating the ligand binding property of the aptamer by making two extended variants that can form three or four G-quartet G4 structures. Through equilibrium binding and electrospray ionization mass spectrometry (ESI-MS) analysis, we observed a stronger affinity of aptamers to ATP by the variant G4 constructs relative to the native aptamer (Kd range of 0.040-0.042 μM for variants as compared to 0.15 μM for the native ATP aptamer). Additionally, we observed a dual binding of ThT and ATP to the G4 constructs in the label-free and ESI-MS analyses. These findings together suggest that the G4 motif in the ATP aptamer is a critical structural element that is required for optimum ATP binding and can be modulated for the binding of multiple ligands. These findings are instrumental for designing smart molecular tools for a wide range of applications, including biomarker monitoring and ligand binding studies.


  • Open Access

    Discriminative Stimulus Effects of 30.0 and 300.0 mg/kg Gabapentin in Rats: Substitution Testing with Morphine and Fentanyl

    by Alexia G. Dalton, Madeline T. Van Fossen, Alexandria Iannucci, Joshua Prete, Taylor Galaszewski, Dillon S. Shekoski, Bethany E. Beavers, Adam J. Prus

    ID 56087 Poster Board 416 Gabapentin is a blocker for Ca2+ channels that contain an α2Δ-1 or α2Δ-2 subunit and is prescribed for neuropathic pain, anxiety, fibromyalgia, and epilepsy. There are increasing reports of abuse with gabapentin, particularly when also used with opioids. These observations suggest that gabapentin may produce positive subjective effects and that these effects may be similar, to some extent, with opioids. In order to examine the subjective effects of gabapentin, the present study utilized a drug discrimination procedure in 22 male adult Sprague Dawley rats trained to discriminate either a 30.0 (30GPN) or 300.0 mg/kg dose (300GPN) of gabapentin versus saline in a two choice operant task for food reinforcement. All rats met the training criteria, consisting of 5 out 6 consecutive sessions of at least 80% condition-appropriate responding. Gabapentin produced full-substitution (>80% drug-lever responding) for 30GPN beginning at a 15.0 mg/kg dose and for 300GPN beginning at a 100.0 mg/kg dose. Morphine produced partial substitution (>20% drug-lever responding) for both training doses, with a 5.0 mg/kg dose of morphine producing partial substitution for both 30GPN (40.9% drug-lever responding) and 300GPN (31.7%). A 10.0 mg/kg dose of morphine also partially substituted for the lowest training dose, 30GPN (64.8%), which significantly reduced response rates (0.5 responses per second [RPS]), but this dose was highly rate suppressant for the 300GPN group (0.02 RPS), which precluded determination of percent drug responding for this dose. A 0.08 mg/kg dose of fentanyl partially substituted for 30GPN (45.6%) and for 300GPN (33.2%). Pretreatment with a 3.0 mg/kg dose of the opioid receptor antagonist naltrexone partially blocked the discriminative stimulus effects of 30GPN (69.5%) and 300GPN (69.8%). The present findings indicate that gabapentin can be readily established as a discriminative cue and that the properties of this cue may be partially mediated by opioid receptors.